Advertisement
Table 1 Baseline characteristics of the study population
| Characteristic | OGTT in stroke (n = 59) | OGTT controls (n = 27) | Total rtPA cohort (n = 379) |
|---|---|---|---|
| Age, years | 70.6 (61.5–76.2) | 44.6 (27.9–68.3) | 74.5 (65.3–83.3) |
| Male sex (%) | 66.1 | 40.7 | 51.4 |
| NIH before tPA | 4 (3–6) | – | 6 (3–12.5) |
| mRS discharge | 1 (1–3) | – | 2 (1–4) |
| BMI, kg/m2 | 26.2 (23.4–29.3) | 22.7 (21.2–26.0) | 24.9 (22.9–28.4) |
| eGFR, ml min−1 (1.73 m)−2 | 70 (59–76) | – | 64 (51–76) |
| Admission glucose mmol/L | 6.8 (6.0–7.5) | – | 6.7 (5.9–8.0) |
| Hypertension | 54% | – | 56% |
| Systolic BP, mmHg | 154 (140–176) | – | 157 (140–173) |
| Diastolic BP, mmHg | 89 (80–98.5) | – | 83.5 (75–93) |
| Atrial fibrillation (%) | 14 | – | 20 |
| Current smokers (%) | 10 | – | 12 |
| Prev. diabetes (%) | 0 | 0 | 15 |
| Pathologic OGTT (%) | 57.6 | 11.1 | – |
| Normal glucose tolerance | 42.4 | 88.9 | – |
| Fasting hyperglycemia | 18.6 | 3.7 | – |
| Impaired glucose tolerance | 52.5 | 11.1 | – |
| Diabetes | 5.1 | 0 | – |
